Discovered by BIOTEC research team together with the Medicines for Malaria Venture (MMV), the patented P218 compound was designed based-on 3-dimensional structures of malaria protein target, dihydrofolate reductase, in order to circumvent mutations that had led to resistance to pyrimethamine, […]
Recent Posts
- USDA, U.S. Embassy Bangkok Representatives Visit BIOTEC for Strategic Collaboration in Agricultural Innovation
11/12/2024 - Invitation to attend "the 3rd International Conference on Rice for the Future"
10/15/2024 - Discover the way to achieve SDG 2 goals together in this exciting talk by Dr. Pattamaporn Prachomrat this Wednesday (October 16th, 2024)
10/13/2024